172 related articles for article (PubMed ID: 29478238)
1. Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation.
Jandali MB
Clin Drug Investig; 2018 Jun; 38(6):503-508. PubMed ID: 29478238
[TBL] [Abstract][Full Text] [Related]
2. Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure.
Compagner CT; Wysocki CR; Reich EK; Zimmerman LH; Holzhausen JM
Am J Emerg Med; 2022 Dec; 62():49-54. PubMed ID: 36252310
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction.
Hirschy R; Ackerbauer KA; Peksa GD; O'Donnell EP; DeMott JM
Am J Emerg Med; 2019 Jan; 37(1):80-84. PubMed ID: 29731345
[TBL] [Abstract][Full Text] [Related]
5. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
Hasbrouck M; Nguyen TT
Am J Emerg Med; 2022 Aug; 58():39-42. PubMed ID: 35623182
[TBL] [Abstract][Full Text] [Related]
6. Acute rate control with metoprolol versus diltiazem in atrial fibrillation with heart failure with reduced ejection fraction.
Kapustova K; Phan B; Allison-Aipa T; Choi M
Am J Emerg Med; 2023 May; 67():126-129. PubMed ID: 36871480
[TBL] [Abstract][Full Text] [Related]
7. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
Hines MC; Reed BN; Ivaturi V; Bontempo LJ; Bond MC; Hayes BD
Am J Health Syst Pharm; 2016 Dec; 73(24):2068-2076. PubMed ID: 27919874
[TBL] [Abstract][Full Text] [Related]
8. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.
Goldenberg IF; Lewis WR; Dias VC; Heywood JT; Pedersen WR
Am J Cardiol; 1994 Nov; 74(9):884-9. PubMed ID: 7977118
[TBL] [Abstract][Full Text] [Related]
9. Improving Appropriate Dosing of Intravenous dilTIAZem in Patients With Atrial Fibrillation or Flutter With Rapid Ventricular Response in the Emergency Department.
Pon G; Pelsue B; Gulbis B
J Emerg Nurs; 2020 Mar; 46(2):246-253. PubMed ID: 31839326
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
Heywood JT
Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
[TBL] [Abstract][Full Text] [Related]
11. The use of diltiazem for treating rapid atrial fibrillation in the out-of-hospital setting.
Wang HE; O'connor RE; Megargel RE; Schnyder ME; Morrison DM; Barnes TA; Fitzkee A
Ann Emerg Med; 2001 Jan; 37(1):38-45. PubMed ID: 11145769
[TBL] [Abstract][Full Text] [Related]
12. Low-dose diltiazem in atrial fibrillation with rapid ventricular response.
Lee J; Kim K; Lee CC; Nam YW; Lee JH; Rhee JE; Singer AJ; Kim KS; Ro Y
Am J Emerg Med; 2011 Oct; 29(8):849-54. PubMed ID: 20825912
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
[TBL] [Abstract][Full Text] [Related]
14. Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial Fibrillation.
Cholack G; Garfein J; Krallman R; Montgomery D; Kline-Rogers E; Rubenfire M; Bumpus S; Md TC; Barnes GD
Am J Med; 2021 Nov; 134(11):1413-1418.e1. PubMed ID: 34245675
[TBL] [Abstract][Full Text] [Related]
15. Intravenous diltiazem and acute renal failure after cardiac operations.
Young EW; Diab A; Kirsh MM
Ann Thorac Surg; 1998 May; 65(5):1316-9. PubMed ID: 9594859
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
Xiao SQ; Ibarra F; Cruz M
Ann Pharmacother; 2022 Aug; 56(8):916-921. PubMed ID: 34738470
[TBL] [Abstract][Full Text] [Related]
17. Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response.
Ward SM; Radke J; Calhoun C; Caporossi J; Hall GA; Matuskowitz AJ; Weeda ER; Weant KA
Am J Emerg Med; 2020 Nov; 38(11):2271-2276. PubMed ID: 31753621
[TBL] [Abstract][Full Text] [Related]
18. Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison.
Hassan S; Slim AM; Kamalakannan D; Khoury R; Kakish E; Maria V; Ahmed S; Pires LA; Kronick SL; Oral H; Morady F
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):227-31. PubMed ID: 17875950
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
[TBL] [Abstract][Full Text] [Related]
20. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
Eur J Heart Fail; 2012 Mar; 14(3):295-301. PubMed ID: 22294759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
